Streptozotocin-induced diabetic models in mice and rats

Furman, Brian L. (2021) Streptozotocin-induced diabetic models in mice and rats. Current Protocols, 1. e78. ISSN 2691-1299

[thumbnail of Furman-CP-2021-Streptozotocin-induced-diabetic-models]
Preview
Text (Furman-CP-2021-Streptozotocin-induced-diabetic-models)
Furman_CP_2021_Streptozotocin_induced_diabetic_models.pdf
Final Published Version
License: Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 logo

Download (577kB)| Preview

    Abstract

    Streptozotocin (STZ) is an antibiotic that causes pancreatic islet β‐cell destruction and is widely used experimentally to produce a model of type 1 diabetes mellitus (T1DM). Detailed in this article are protocols for producing STZ‐induced insulin deficiency and hyperglycemia in mice and rats. Also described are protocols for creating animal models for type 2 diabetes using STZ. These animals are employed for assessing the pathological consequences of diabetes and for screening potential therapies for the treatment of this condition.